In OCI-AML-3, exposure to ABT-199 also resulted in a partial displacement of BIM and PUMA from BCL-2, despite the cells being largely resistant to ABT-199 (Fig. 2c). The gene discussed is BCL2; the disease is acute myeloid leukemia.